Silicon Valley Bank released its healthcare investments and exits trend report for the first half of 2019. It shows, among other things, oncology losing its first-place status in terms of Series A dollars raised.
Venture capital fundraising this year by biopharma startups is on course to fall behind last year, though it will be above the figure for 2017. But the biggest story may be where that funding is going.
Silicon Valley Bank released its 2019 midyear report, “Trends in Healthcare Investments and Exits 2019,” on Thursday. So far, healthcare companies have raised $5.8 billion in the first half of this year, compared with $9.6 billion for all of 2018 and $9.1 billion in 2017.
But one of the most noteworthy trends is that oncology appears to have lost its first-place status in terms of Series A dollars raised. Although oncology saw the largest number of deals by indication, with 21 Series A rounds, oncology companies raised $483 million. By contrast, companies focused on development platforms saw 20 Series A deals valued at $659 million.
“If you go back historically, oncology has dominated venture investing since 2013,” said SVB Managing Director and report author Jon Norris, in a phone interview.
Image Credit: Silicon Valley Bank
News This Week
What if you didn’t need surgery to implant a pacemaker on a faulty heart? What if you could control your blood sugar levels without an injection of insulin, or mitigate the onset of a [...]
Guided by artificial intelligence and powered by a robotic platform, a system developed by MIT researchers moves a step closer to automating the production of small molecules that could be used in medicine, solar [...]
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating. Scientists at Texas Heart Institute (THI) report they have [...]
The lab of Cheryl Kerfeld at Michigan State University has created a synthetic nano-sized factory, based on natural ones found in bacteria. This research could someday lead to new medical, industrial or bioenergy [...]
Melanoma in skin biopsy with H&E stain — this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0 Researchers at Tel Aviv University have developed a novel nano-vaccine for melanoma, the most aggressive [...]
Modern light microscopic techniques provide extremely detailed insights into organs, but the terabytes of data they produce are usually nearly impossible to process. New software, developed by a team led by MDC scientist Dr. [...]
It has long been known that gold can be used to do things that philosophers have never even dreamed of. The Institute of Nuclear Physics of the Polish Academy of Sciences in Cracow has [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - August 6 2019 Since [...]
DARPA has awarded funding to six organizations to support the Next-Generation Nonsurgical Neurotechnology (N3) program, first announced in March 2018. Battelle Memorial Institute, Carnegie Mellon University, Johns Hopkins University Applied Physics Laboratory, Palo Alto [...]
Source: Bold Business. Follow them on twitter. Though you may not realize it, more than 40,000 computer-brain interfaces have already been employed in healthcare today. Thus, to say computer-brain interfaces are something new would [...]
It is hard to imagine just how small one nanometer—one-billionth of a meter—really is. Ten hydrogen atoms in a row are one nanometer long. For perspective, consider that a sheet of paper is 75,000 [...]
Scientists at Ben-Gurion University of the Negev (BGU) have designed a new chip device that provides excellent identification of minuscule blood residues for forensic applications. Criminologists detect microscopic blood drops, as well as DNA, [...]